---
title: "CSPC Pharmaceutical Group: Revenue, licensing income and pipeline milestones advanced alongside a 73.6% 1-9M gross margin"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305926514.md"
description: "1-9M revenue rose 10.9% to RMB25.26bn, with gross margin reaching 73.6%; Q3 finished-drug sales grew 10.1%. Licensing income and clinical progress supported expansion, while more than 30 product launches are planned for 2026-2028.Original document: CSPC Pharmaceutical Group Limited [1093] Slides Release — Nov. 18 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-11-18T06:51:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305926514.md)
  - [en](https://longbridge.com/en/news/305926514.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305926514.md)
generator: "portal-rs"
---

# CSPC Pharmaceutical Group: Revenue, licensing income and pipeline milestones advanced alongside a 73.6% 1-9M gross margin

1-9M revenue rose 10.9% to RMB25.26bn, with gross margin reaching 73.6%; Q3 finished-drug sales grew 10.1%. Licensing income and clinical progress supported expansion, while more than 30 product launches are planned for 2026-2028.

Original document: CSPC Pharmaceutical Group Limited \[1093\] Slides Release — Nov. 18 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)

## Related News & Research

- [CSPC Starts Phase I/II Trial of SYS6055 for B-Cell Non-Hodgkin Lymphoma in China](https://longbridge.com/en/news/304626206.md)
- [CSPC’s Anbenitamab Regimen Cuts Death Risk 61% in Phase III Gastric Cancer Trial](https://longbridge.com/en/news/303074350.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [Moonshot drops $150M Indonesia Nvidia rental days after US loophole crackdown](https://longbridge.com/en/news/306145817.md)
- [PRESS DIGEST-New York Times business news - November 20](https://longbridge.com/en/news/306242079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**